The big medical news of 2026 is about the big blockbuster drug of 2025. Semaglutide (a.k.a. Ozempic, a.k.a. Wegovy) is now off patent in Canada. In the U.S. and the rest of the world, patent ...
On January 8, 2026, Collegium Pharmaceutical, Inc. issued full-year 2026 guidance, projecting US$805 million to US$825 million in net product revenues and highlighting new authorized generic supply ...
The Food and Drug Administration (FDA) approved a generic version of the abortion pill mifepristone in October, making chemical abortion more affordable and accessible to pregnant women who wish to ...
Abstract: Mobile Crowdsensing (MCS) has become a popular sensing paradigm, where a number of participants use their mobile devices to collectively share and extract information related to a certain ...
U.S President Donald Trump's move to impose 100% tariffs on patented, branded drugs are expected to have a limited impact on India's pharma industry. Most Indian drugmakers sell generic pharmaceutical ...
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options ...
Functional programming, as the name implies, is about functions. While functions are part of just about every programming paradigm, including JavaScript, a functional programmer has unique ...
Many middle-income countries are left out of the deal, widening a gulf in access to critical medicines. By Stephanie Nolen Stephanie Nolen has covered the global H.I.V. pandemic for more than 25 years ...
SHANGHAI, June 6 (Reuters) - Novo Nordisk is facing the prospect of intensifying competition in the promising Chinese market where drugmakers are developing at least 15 generic versions of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results